Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:August 2008
End Date:December 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Effect of Statins on Cerebral Blood Flow After Subarachnoid Hemorrhage

The primary objective of this project is to investigate the effect of statin therapy on
cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not
receive statins in a blinded design.

We will determine if statin therapy improves CBF in patients with aneurysmal subarachnoid
hemorrhage. This improvement, if present, may be due to improved basal CBF, improved
autoregulatory function, or a mitigation of large arterial narrowing. The information gain
from this study will help us to better understand the mechanism of action of statins. This
knowledge may be useful in the design of future studies with statins and in the development
of other therapies aimed at similar mechanisms.

Inclusion Criteria:

- Age > 18

- SAH from ruptured cerebral aneurysm within 48 hours of admission.

- Modified Fisher grade 2,3,or 4

- Planned surgical or endovascular aneurysm repair

Exclusion Criteria:

- Pregnancy

- SAH secondary to traumatic or mycotic aneurysms

- Pre-ictal statin therapy

- Contraindication to stain therapy

- WFNS grade 5

- Contraindications to MAP elevation on day 7-10
We found this trial at
1
site
Washington Univeristy
ST Louis, Missouri 63110
?
mi
from
ST Louis, MO
Click here to add this to my saved trials